Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

13.68
+0.21001.56%
Post-market: 13.680.00000.00%16:20 EDT
Volume:908.63K
Turnover:12.41M
Market Cap:2.22B
PE:620.74
High:13.82
Open:13.48
Low:13.45
Close:13.47
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:0.58
T/O Rate:1.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:9.19
PE(LYR):308.14

Loading ...

Tasmea frees escrowed shares tied to Vertex acquisition

TIPRANKS
·
Jun 01

Assessing Vertex Pharmaceuticals (VRTX) Valuation After Health Canada Review Progress For Suzetrigine

Simply Wall St.
·
May 29

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 29

Armstrong installs Templok energy-saving ceilings at Swinerton Spokane office renovation, unlocking 48E tax credits

Reuters
·
May 29

Armstrong retrofits facilities with Templok energy-saving ceilings, taps federal energy storage tax credits

Reuters
·
May 29

Vertex to Cancel 2.8 Million Treasury Shares to Cut Dilution Risk

TIPRANKS
·
May 28

Vertex Corp. Launches ¥1 Billion Share Buyback to Boost Capital Efficiency

TIPRANKS
·
May 28

Health Canada Review Puts Vertex’s Suzetrigine And Valuation In Focus

Simply Wall St.
·
May 23

Vertex Pharmaceuticals Says New Pain Management Drug Is Under Review at Health Canada

Dow Jones
·
May 22

Vertex announces Health Canada acceptance of NDS for suzetrigine

TIPRANKS
·
May 22

J.P. Morgan Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
May 20

Vertex study shows only 12% of firms have fully integrated tax technology

Reuters
·
May 19

New Vertex Research Highlights Rising Revenue Risk from IT, Tax, and Finance Misalignment

GlobeNewswire
·
May 19

Vertex Steps Into Autoimmune Care: Mid-Stage Myasthenia Gravis Trial Shows Growing Pipeline Ambition

TIPRANKS
·
May 19

Vertex Corp launches long-term stock option plan for directors

TIPRANKS
·
May 18

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 16

Daiwa Securities Adjusts PT on Vertex Pharmaceuticals to $555 From $561, Maintains Buy Rating

MT Newswires Live
·
May 15

Vertex Sees FY Net Y4.70B

Dow Jones
·
May 14

Press Release: Vertex Resource Group Ltd. Reports First Quarter 2026 Results

Dow Jones
·
May 14

Vertex Shareholders Endorse Board, Governance and Equity Plan

TIPRANKS
·
May 14